U.S. MedSys Corp. Announces Year-End Financial Results.

DENVER -- U.S. MedSys Corp. (OTCBB:UMSY) (OTCBB:UMSYE) announced it has filed its annual report on Form 10-KSB for the fiscal year ended June 30, 2004. UMSY is a medical network development, marketing, and distribution organization which provides medical technology and support services to the healthcare industry.

E[acute accent]Following is a summary of select financial highlights.

E[acute accent]As of June 30, 2004, the company reported total assets of $3,018,040, total liabilities of $133,173 and shareholder equity of $2,884,867.

E[acute accent]For the year, the company reported revenue of $201,820, a net loss of $1,891,495 and a net loss per share of $.08.

E[acute accent]Investors are encouraged to review the complete report available at www.sec.gov or at the company's website at www.usmedsyscorp.com.

E[acute accent]Peter G. Futro, CEO, said, "We are pleased with the performance exhibited by our company during our emergence from being a development stage business. During the past year, we have developed and implemented an integrated growth program for our companies. We are very excited about the ability to present a multi-faceted delivery system for disease management, further augmenting our technology placement program. As an example, the combination of Global Medical Direct, LLC (GMD) and PMC/Foot Care, LLC allows products and services in the diabetes area to be integrated with foot care to create a cost effective and balanced disease management program. We are continuing to implement a strategy that can provide service without the inefficiencies that arise in moving between care organizations. We feel this balanced approach is the future of disease management and healthcare."

E[acute accent]About U.S. MedSys Corp.

E[acute accent]U.S. MedSys Corp. is a network development, marketing, and distribution organization which provides medical technology and support services to the healthcare industry. U.S. MedSys Corp. is focusing on its core competencies in network development and marketing. As well as U.S. MedSys Corp., the UMSY business network consists of PMC/Foot Care, LLC, the largest podiatric network in the U.S.; Global Medical Direct, LLC (GMD), a network provider of sales, marketing and distribution of self-management products and services to patients with diabetes; contractual relationships with Practice Management Corp., a third-party administrator and New York Home Health Care Equipment, which provides comprehensive services to hospitals, long term care facilities and home care patients in the metropolitan New York and New Jersey area. The company out-sources other functions, such as manufacturing, related engineering and product development. For more information see www.usmedsyscorp.com.

E[acute accent]This press release contains "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. Actual results could differ materially, as the result of such factors as competition in the markets for the company's products and services and the ability of the company to execute its plans. By making these forward-looking statements, the company can give no assurances that transactions described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.